Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Cardiovascular device companies
1. Cardiovascular Device Companies: Surveying the Global
Competitive Landscape
This continuously-updated report enables customers to evaluate the device technologies
competitive landscape and identify the companies to look out for in the future. It provides an
insight into who’s striking strategic and tactical partnerships, along with the latest in regulatory
developments and M&A activity.
A complete picture...
This expanded and fully revised 414-page report provides a complete picture of how robust the
cardiovascular device sector is and how well companies are performing. The report is organised
into 2 sections:
AN OVERVIEW OF PRODUCT APPROVALS AND REGULATORY ISSUES IN THE
US, EUROPE AND BEYOND
This insightful overview throws the spotlight on the regulatory climate for cardiovascular device
companies in the US and Europe. It examines the process for approving products in the US, the
impact of potential regulatory changes in the US and improvements to the EU regulatory
process.
A DETAILED REVIEW OF 60 COMPANIES
Key areas covered for each carefully selected company include:
Company Overview
Key Personnel
Key Milestones
Competitor Analysis
Products/Technologies
R&D and Research Strategy
Key Agreements and Alliances
Financial Data
Comprehensive Contact Details
This report is an essential desk reference and a timely aid to market planning and competitor
awareness. Importantly it does not just concentrate on the sector’s leading lights but also
examines some of the smaller innovators that sometimes get overlooked until they get snapped
up by the big companies.
Now in its seventh year of publication the report is driven by the latest takeovers and new
entrants. The report has been written and researched by Espicom’s experts in the field Lawrence
Miller, who also edits the respected newsletter Cardiovascular Device Business, and Sarah
Tomblin. The report is backed by a regular newsfeed of cardiovascular device articles that
collectively provide a compelling package of competitive data. No other report provides such a
level of complimentary information.
2. Shining the spotlight on 60 companies who lead the market with novel and progressive
technologies 60 companies assessed
Abbott Laboratories
Abiomed
Advanced Cardiac Therapeutics
AorTech International
Arterial Remodeling Technologies
AtCor Medical
AtriCure
Berlin Heart
Bioheart
Biosensors International
Biotronik
Blue Medical
Boston Scientific
B Braun
Cambridge Heart
CardiacAssist
Cardica
CardioFocus
CardioKinetix
CardioMEMS
Cardionovum
Carmat
CircuLite
Cordis
CorMatrix Cardiovascular
Defibtech
Deltex Medical
Edwards Lifesciences
Elixir Medical
Endologix
Endosense
Getinge AB
Heartware International
Hexacath
Jarvik Heart
Impulse Dynamics
InspireMD
LeMaitre Vascular
Lombard Medical
Medtronic
MiCardia
Miracor Medical Systems
nContact
3. Opto Circuits (India)
OrbusNeich
Reva Medical
Sahajanand Medical Technologies
SeptRX
Sorin
Stereotaxis
St Jude Medical
Sunshine Heart
SynCardia Systems
Teleflex
Terumo
Thoratec
Vascular Solutions
Volcano
World Heart
Zoll Medical
Covering all major cardiovascular device technologies
AEDS/Defibrillators
ICD/CRT-Ds
Cardiac/Ventricular Assist Devices
Artificial Hearts
Renal Denervation Systems
Cardiac Ablation Devices
Stents – including bare metal, drug-eluting and bioreabsorbable models
Endovascular Stent Grafts
Heart Valves (including biological)
ECGs
Leads/Guidewires
Embolic Protection Devices
Intra-aortic Balloon Pumps
Use this report to...
Highlight the emerging companies in the industry
Evaluate the competitive landscape and identify the companies to watch
Know who’s striking strategic and tactical partnerships#
Monitor M&A activity and the changing competitive landscape
Stay in touch with the make-up and performance of the industry
Understand the trends which are shaping the sector’s operation
Identify the leading products - this report showcases them!
Get the best from your investment. Pdf or print formats and the brilliant Espicom
Interactive!
4. Customers can choose print or pdf format, but all get access via Espicom Interactive. Customers
will benefit from accessing this report’s rich content through Espicom Interactive, by:
Accessing daily-reviewed company reports, updates and news
Intuitively cross file searching and getting fast results
Saving time and effort by extracting data with instant “one click” export to MS ExcelTM
and MS PowerPointTM
Using the machine translation tool to translate text into 9 leading languages
Easily building their own reports from all the content
Get more information @ http://www.reportsnreports.com/reports/180401-cardiovascular-device-
companies-surveying-the-global-competitive-landscape.html
Report Details
Published: June 2012
No.of Pages: 414
Price: Single User License: US$1740
Table of Contents
AN OVERVIEW OF REGULATORY ISSUES IN THE US, EUROPE AND BEYOND 1
Abbott Laboratories 15
KEY PERSONNEL 15
COMPANY OVERVIEW 15
KEY MILESTONES 15
R&D MILESTONES 16
TECHNOLOGIES/PRODUCTS 17
FINANCIALS 26
Abiomed 27
KEY PERSONNEL 27
COMPANY OVERVIEW 27
KEY COMPETITORS . 27
KEY MILESTONES 28